Integra Earnings: Neutral Outlook Ahead | Business and Finance News

Integra LifeSciences is set to drop its earnings report with neutral expectations—revenue is forecast to hold steady after a recent beat, but past misses loom. While competitors like Intuitive Surgical and Abbott surged, Integra’s stock has outperformed the sector, trading near $19.60 with a target around $18.63. Analysts see little change in outlook, making this a quiet, hold-the-line moment for the healthcare equipment player. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f33e1372f0522180